Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_assertion type Assertion NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_head.
- NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_assertion description "[Additionally, a recent study revealed a possible beneficial effect of antihuman CD20 antibody (rituximab) therapy for SSc patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_provenance.
- NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_assertion evidence source_evidence_literature NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_provenance.
- NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_assertion SIO_000772 20175836 NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_provenance.
- NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_assertion wasDerivedFrom befree-20150227 NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_provenance.
- NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_assertion wasGeneratedBy ECO_0000203 NP911271.RA7Uwp2IkhS8Ye52FDTry1bElz0lpFo5rhjIUg5ry-gVY130_provenance.